Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis
Clinical trial NCT04999020 · TERMINATED
Trial details
- NCT number
- NCT04999020
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2023-10-26
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.